Kinetic Landscape of Single Virus-like Particles Highlights the Efficacy of SARS-CoV-2 Internalization

被引:2
|
作者
Atemin, Aleksandar [1 ]
Ivanova, Aneliya [1 ]
Peppel, Wiley [2 ,3 ]
Stamatov, Rumen [1 ]
Gallegos, Rodrigo [2 ,3 ]
Durden, Haley [2 ,3 ]
Uzunova, Sonya [1 ]
Vershinin, Michael D. [2 ,3 ,4 ]
Saffarian, Saveez [2 ,3 ,4 ]
Stoynov, Stoyno S. [1 ]
机构
[1] Bulgarian Acad Sci, Inst Mol Biol, 21 G Bontchev Str, BU-1113 Sofia, Bulgaria
[2] Univ Utah, Dept Phys & Astron, Salt Lake City, UT 84112 USA
[3] Univ Utah, Ctr Cell & Genome Sci, Salt Lake City, UT 84112 USA
[4] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA
来源
VIRUSES-BASEL | 2024年 / 16卷 / 08期
关键词
SARS-CoV-2; dynamics; virus internalization; Omicron; nucleocapsid release; virus-like particles; dynamin; single-particle tracking; DYNAMIN; PH; INFECTION; STABILITY; PROTEIN; CELLS;
D O I
10.3390/v16081341
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The efficiency of virus internalization into target cells is a major determinant of infectivity. SARS-CoV-2 internalization occurs via S-protein-mediated cell binding followed either by direct fusion with the plasma membrane or endocytosis and subsequent fusion with the endosomal membrane. Despite the crucial role of virus internalization, the precise kinetics of the processes involved remains elusive. We developed a pipeline, which combines live-cell microscopy and advanced image analysis, for measuring the rates of multiple internalization-associated molecular events of single SARS-CoV-2-virus-like particles (VLPs), including endosome ingression and pH change. Our live-cell imaging experiments demonstrate that only a few minutes after binding to the plasma membrane, VLPs ingress into RAP5-negative endosomes via dynamin-dependent scission. Less than two minutes later, VLP speed increases in parallel with a pH drop below 5, yet these two events are not interrelated. By co-imaging fluorescently labeled nucleocapsid proteins, we show that nucleocapsid release occurs with similar kinetics to VLP acidification. Neither Omicron mutations nor abrogation of the S protein polybasic cleavage site affected the rate of VLP internalization, indicating that they do not confer any significant advantages or disadvantages during this process. Finally, we observe that VLP internalization occurs two to three times faster in VeroE6 than in A549 cells, which may contribute to the greater susceptibility of the former cell line to SARS-CoV-2 infection. Taken together, our precise measurements of the kinetics of VLP internalization-associated processes shed light on their contribution to the effectiveness of SARS-CoV-2 propagation in cells.
引用
收藏
页数:22
相关论文
共 50 条
  • [41] SARS-CoV-2 Virus-like Particles with Plasmonic Au Cores and S1-Spike Protein Coronas
    Andrzejewska, Weronika
    Peplinska, Barbara
    Litowczenko, Jagoda
    Obstarczyk, Patryk
    Olesiak-Banska, Joanna
    Jurga, Stefan
    Lewandowski, Mikolaj
    ACS SYNTHETIC BIOLOGY, 2023, 12 (08): : 2320 - 2328
  • [42] SARS-COV-2 Viral Budding and Entry can be Modeled Using BSL-2 Level Virus-Like Particles
    Plescia, Caroline
    David, Emily
    Patra, Dhabaleswar
    Sengupta, Ranjan
    Amiar, Souad
    Su, Yuan
    Stahelin, Robert
    FASEB JOURNAL, 2021, 35
  • [43] Structural stability of SARS-CoV-2 virus like particles degrades with temperature
    Sharma, A.
    Preece, B.
    Swann, H.
    Fan, X.
    McKenney, R. J.
    Ori-McKenney, K. M.
    Saffarian, S.
    Vershinin, M. D.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 534 : 343 - 346
  • [44] SARS-CoV-2 Subunit Virus-like Vaccine Demonstrates High Safety Profile and Protective Efficacy: Preclinical Study
    Vakhrusheva, Anna V.
    Kudriavtsev, Aleksandr V.
    Kryuchkov, Nickolay A.
    Deev, Roman V.
    Frolova, Maria E.
    Blagodatskikh, Konstantin A.
    Djonovic, Milana
    Nedorubov, Andrey A.
    Odintsova, Elena
    Ivanov, Aleksandr V.
    Romanovskaya-Romanko, Ekaterina A.
    Stukova, Marina A.
    Isaev, Artur A.
    Krasilnikov, Igor V.
    VACCINES, 2022, 10 (08)
  • [45] Rapid assessment of SARS-CoV-2-evolved variants using virus-like particles
    Syed, Abdullah M.
    Taha, Taha Y.
    Tabata, Takako
    Chen, Irene P.
    Ciling, Alison
    Khalid, Mir M.
    Sreekumar, Bharath
    Chen, Pei-Yi
    Hayashi, Jennifer M.
    Soczek, Katarzyna M.
    Ott, Melanie
    Doudna, Jennifer A.
    SCIENCE, 2021, 374 (6575) : 1626 - +
  • [46] SARS-CoV-2 Virus-like Particles Produced by a Single Recombinant Baculovirus Generate Anti-S Antibody and Protect against Variant Challenge
    Sullivan, Edward
    Sung, Po-Yu
    Wu, Weining
    Berry, Neil
    Kempster, Sarah
    Ferguson, Deborah
    Almond, Neil
    Jones, Ian M.
    Roy, Polly
    VIRUSES-BASEL, 2022, 14 (05):
  • [47] Induction of Broadly Cross-Reactive Antibodies by Displaying Receptor Binding Domains of SARS-CoV-2 on Virus-like Particles
    Chang, Xinyue
    Liu, Xuelan
    Mohsen, Mona O.
    Zeltins, Andris
    Martina, Byron
    Vogel, Monique
    Bachmann, Martin F.
    VACCINES, 2022, 10 (02)
  • [48] Rapid quantitative screening assay for SARS-CoV-2 neutralizing antibodies using HiBiT-tagged virus-like particles
    Miyakawa, Kei
    Jeremiah, Sundararaj Stanleyraj
    Ohtake, Norihisa
    Matsunaga, Satoko
    Yamaoka, Yutaro
    Nishi, Mayuko
    Morita, Takeshi
    Saji, Ryo
    Nishii, Mototsugu
    Kimura, Hirokazu
    Hasegawa, Hideki
    Takeuchi, Ichiro
    Ryo, Akihide
    JOURNAL OF MOLECULAR CELL BIOLOGY, 2020, 12 (12) : 987 - 990
  • [49] SARS-CoV-2 Virus-like Particles (VLPs) Specifically Detect Humoral Immune Reactions in an ELISA-Based Platform
    Hirschberg, Stefan
    Bauer, Hannes
    Kamhieh-Milz, Julian
    Ringel, Frauke
    Harms, Christoph
    Eddin, Omar Kamal
    Pruss, Axel
    Hanack, Katja
    Schulze-Forster, Kai
    ANTIBODIES, 2022, 11 (04)
  • [50] Design and Immunological Properties of the Novel Subunit Virus-like Vaccine against SARS-CoV-2
    Krasilnikov, Igor V.
    Kudriavtsev, Aleksandr V.
    Vakhrusheva, Anna V.
    Frolova, Maria E.
    Ivanov, Aleksandr V.
    Stukova, Marina A.
    Romanovskaya-Romanko, Ekaterina A.
    Vasilyev, Kirill A.
    Mushenkova, Nataliya V.
    Isaev, Artur A.
    VACCINES, 2022, 10 (01)